VaramirStart free · no cardSign in
MDGL as of Oct 31 · 18:10 ET
MDGLNasdaqPharmaceutical Preparations

Madrigal Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±10.2%
avg realized
±9.0%
Jan 13 '25±8.9%▼−10.39%×1.17
Feb 26 '25±13.4%▲+14.99%×1.12
May 1 '25±11.3%▼−1.86%×0.17
Aug 5 '25±9.2%▲+8.59%×0.93
Nov 4 '25±12.9%▲+7.83%×0.61
Feb 19 '26±6.2%▼−11.11%×1.78
Q1 FY26±9.2%▲+7.42%×0.80
Q2 FY26±10.5%▼−9.83%×0.94
quarterimplied−15%0+15%realized×
Q2 FY26±10.5%▼−9.83%×0.94
Q1 FY26±9.2%▲+7.42%×0.80
Feb '26±6.2%▼−11.11%×1.78
Nov '25±12.9%▲+7.83%×0.61
Aug '25±9.2%▲+8.59%×0.93
May '25±11.3%▼−1.86%×0.17
2 older reports
Feb '25±13.4%▲+14.99%×1.12
Jan '25±8.9%▼−10.39%×1.17
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

417managers reporting a position in the latest quarterly filings13F · Jun 30 '26
33managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

Bear2

10 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
−2.50%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

MDGL report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±12.4% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.